{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:29Z","timestamp":1792098449623,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jacc.2018.11.042","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T16:22:29Z","timestamp":1550506949000},"page":"795-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Effects of Sacubitril\/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients\u00a0With HFrEF"],"prefix":"10.1016","volume":"73","author":[{"given":"Michael R.","family":"Zile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"O'Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.11.042_bib1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonz\u00e1lez","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib2","doi-asserted-by":"crossref","first-page":"e002613","DOI":"10.1161\/JAHA.115.002613","article-title":"Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage","volume":"4","author":"Schelbert","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2018.11.042_bib3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.11.042_bib4","doi-asserted-by":"crossref","unstructured":"Bradshaw AD. The extracellular matrix. In: Bradshaw RA, Stahl PD, editors-in-chief. Encyclopedia of Cell Biology. Vol. 2. Waltham, MA: Academic Press, 2016:694\u2013703.","DOI":"10.1016\/B978-0-12-394447-4.20067-9"},{"key":"10.1016\/j.jacc.2018.11.042_bib5","doi-asserted-by":"crossref","first-page":"H1128","DOI":"10.1152\/ajpheart.00482.2012","article-title":"Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing","volume":"303","author":"Baicu","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib6","doi-asserted-by":"crossref","first-page":"H92","DOI":"10.1152\/ajpheart.00719.2017","article-title":"Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis","volume":"315","author":"McDonald","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCHEARTFAILURE.110.958199","article-title":"Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure","volume":"4","author":"Zile","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib8","doi-asserted-by":"crossref","first-page":"e002551","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551","article-title":"Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction: data from the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study","volume":"9","author":"Zile","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib9","doi-asserted-by":"crossref","first-page":"e007885","DOI":"10.1161\/JAHA.117.007885","article-title":"Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"7","author":"Duprez","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2018.11.042_bib10","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.2174\/1381612823666170317124125","article-title":"Circulating biomarkers of collagen metabolism and prognosis of heart failure with reduced or mid-range ejection fraction","volume":"23","author":"Ferreira","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacc.2018.11.042_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/eurjhf\/hft052","volume":"15","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.11.042_bib13","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cardfail.2012.04.002","article-title":"Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy","volume":"18","author":"Essa","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejheart.2005.06.008","article-title":"Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes","volume":"8","author":"Alla","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCHEARTFAILURE.108.828343","article-title":"Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study","volume":"2","author":"Barasch","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCHEARTFAILURE.113.000665","article-title":"Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy","volume":"7","author":"Ellims","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCHEARTFAILURE.114.001100","article-title":"Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes","volume":"7","author":"O'Meara","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfs179","article-title":"Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure","volume":"15","author":"Kaye","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.11.042_bib20","doi-asserted-by":"crossref","first-page":"e0167582","DOI":"10.1371\/journal.pone.0167582","article-title":"Diastolic left ventricular function in relation to urinary and serum collagen biomarkers in a general population","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2018.11.042_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib22","series-title":"Manual of Laboratory and diagnostic Test","year":"2009"},{"key":"10.1016\/j.jacc.2018.11.042_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3945\/ajcn.116.143255","article-title":"Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study","volume":"105","author":"Chatterjee","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2018.11.042_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinbiochem.2010.02.001","article-title":"Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure","volume":"43","author":"Christenson","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacc.2018.11.042_bib26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2012.192153","article-title":"Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study","volume":"58","author":"Coglianese","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2018.11.042_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma\u2013 the Presage ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2018.11.042_bib28","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.cca.2010.07.014","article-title":"Establishment of reference intervals for soluble ST2 from a United States population","volume":"411","author":"Lu","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2018.11.042_bib29","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/j.amjcard.2015.01.035","article-title":"Soluble ST2\u2013analytical considerations","volume":"115 Suppl 7","author":"Mueller","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.11.042_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","article-title":"Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy","volume":"11","author":"Perazzolo Marra","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.11.042_bib32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.11.042_bib33","first-page":"4","article-title":"Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage","volume":"18","author":"Schelbert","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2018.11.042_bib34","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/eurheartj\/ehs257","article-title":"Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice","volume":"33","author":"Zannad","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.11.042_bib35","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to\u00a0survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.11.042_bib36","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/01.CIR.91.9.2353","article-title":"Normalization of diastolic dysfunction in aortic stenosis late after valve replacement","volume":"91","author":"Villari","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.11.042_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.79.4.744","article-title":"Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement","volume":"79","author":"Krayenbuehl","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.11.042_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1053-2498(00)00321-1","article-title":"Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support","volume":"20","author":"Bruckner","year":"2001","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2018.11.042_bib40","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jacc.2015.08.878","article-title":"Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF","volume":"66","author":"Simpson","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.11.042_bib41","first-page":"452","article-title":"Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry","volume":"6","author":"Canepa","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2018.11.042_bib42","first-page":"463","article-title":"Prognostic modeling in heart failure: time for a reboot","volume":"6","author":"Simpson","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2018.11.042_bib43","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejhf.1301","article-title":"Growth differentiation factor-15 is not modified by sacubitril\/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial","volume":"20","author":"Bouabdallaoui","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718395068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718395068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:19:20Z","timestamp":1760015960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718395068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0735109718395068"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.11.042","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Sacubitril\/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients\u00a0With HFrEF","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}